DRIEHAUS CAPITAL MANAGEMENT LLC XENE Holdings History
DRIEHAUS CAPITAL MANAGEMENT LLC's Xenon Pharmaceuticals Inc Holding Summary
As of 2025-03-31, DRIEHAUS CAPITAL MANAGEMENT LLC held 4.58 Mil shares of Xenon Pharmaceuticals Inc(XENE), totaling $153.82 Mil. This investment constitutes 1.48% of their stock portfolio, and DRIEHAUS CAPITAL MANAGEMENT LLC now holds 5.99% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.
The initial trade took place in 2020Q1. And since then DRIEHAUS CAPITAL MANAGEMENT LLC has made 14 purchases of XENE, at an average price of $27.25, for a total of 5.14 Mil shares. In addition, there have been 7 sales at an average price of $36.79 for 559,900.00 shares. Based on historical transaction data and XENE's current price of $31.01, DRIEHAUS CAPITAL MANAGEMENT LLC's estimated gain on his XENE holdings is $22.58 Mil, reflecting a 16.10% gain to date.
DRIEHAUS CAPITAL MANAGEMENT LLC XENE ($31.01) Holding Chart
DRIEHAUS CAPITAL MANAGEMENT LLC XENE ($31.01) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1